You are here

COVID-19

U.S. vaccination supplies will fall sharply because of J&J factory problems.

WASHINGTON — Supplies of Johnson & Johnson’s one-dose coronavirus vaccine will be extremely limited until federal regulators approve production at a Baltimore manufacturing plant with a pattern of quality-control lapses, the White House’s pandemic response coordinator said on Friday.

With allocations of the company’s vaccine set to plunge by 86 percent next week, governors across the country warned that the loss of supplies they had been counting on would set back their vaccination drives.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Scientists are trying to find a simple pill to treat Covid-19 ...but

The world has vaccines that can prevent most cases of Covid-19. It even has drugs that can help with the most serious symptoms of the disease. Now what it needs is a Tamiflu for SARS-CoV-2.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

J&J covid vaccine allocations will be short by 86 per cent next week.

A White House official warned Johnson & Johnson Covid vaccines will be scarce until a troubled plant gains regulatory approval

Supplies of Johnson & Johnson’s one-dose coronavirus vaccine will be extremely limited until federal regulators approve production at a Baltimore manufacturing plant under scrutiny, the White House’s pandemic response coordinator said Friday.

With allocations of the Johnson & Johnson vaccine set to plunge by 86 percent next week, governors across the country warned that the loss of the supplies they were counting on would set back their vaccination drives, which have used the shot in more transient, isolated and rural areas where the one-dose vaccine has appealed to many Americans. The other two vaccines, made by Moderna and Pfizer-BioNTech, continue to flow out to the states at high volume.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to COVID-19
howdy folks
Page loaded in 1.234 seconds.